Although a majority of Americans support medical cannabis, a small segment of the population still opposes its legalization for fear that it will lead to an increase in adolescent cannabis use; however, according to a new study published in the journal Addiction, that fear may be unfounded.

A new medical marijuana guideline developed by Edmonton researchers warns family doctors that the risks may outweigh the benefits for the vast majority of patients. The guideline, published Thursday in the Canadian Family Physician journal, suggests the benefits of medical cannabis may be overstated, and research on its medicinal properties is sorely lacking.

Baby boomers have become a growing market segment in the legal cannabis industry as the acceptance of medical cannabis treatment continues to spread across the world, and now it appears that medical cannabis treatment may offer senior citizens a safer alternative to opioids in the treatment of chronic pain.

DENVER, Feb. 13, 2018 /Weed Wire/ – Colorado-based biotech company Next Frontier Biosciences today announced the assembly of its Research and Development Team, enhancing the company’s lineup of accomplished biotechnology executives and research scientists.

It has often been touted by medical cannabis advocates that states with medical cannabis laws see a statistical reduction in opioid-related deaths, and there is some evidence to support this claim; however, a recent study conducted by the RAND Corporation and the University of California, Irvine, calls into question this assumption and paints a more complex picture.

Marijuana legalization states have taken no steps to limit the potency of marijuana, which has increased sharply in recent years. A new study suggests this could create public health problems down the road as more users become addicted or otherwise impaired.

Who gets to profit from Canada’s booming weed industry? Researchers at The Weekly found that nearly 40 former politicians and police officers are involved in medicinal marijuana companies, set to make retail sales as soon as it becomes legal.

Can cannabis protect individuals from alcohol-related liver damage? Maybe. According to a study published in the journal Liver International, heavy alcohol users that use cannabis on a daily basis have reduced incidence of liver disease than those that do not.

With the Great White North preparing to become the first G7 nation to launch recreational legalization, the federal government wants to inform its journey into uncharted territory by providing $1.4 million in funding to Canadian cannabis research projects.

TORONTO, Ontario, Jan. 24, 2018 /Weed Wire/ – The impact of non-medical cannabis use in Canada has been the subject of much speculation and debate. There are still many uncertainties related to the health, social, and economic implications of cannabis legalization and regulation. A solid evidence base is needed for the ongoing development of the most effective policies, practices, and programs relating to the use of cannabis and its derivatives.

The Department of Veterans Affairs says it will not conduct research into whether medical marijuana could help veterans suffering from post-traumatic stress disorder and chronic pain, as veterans groups are pushing for the use of the drug as an alternative to opioids and anti-depressants.

More pregnant women seem to be using pot — sometimes to ease the nausea of morning sickness or heightened anxiety — and a new study suggests that this slight rise in marijuana use is most pronounced among those younger in age.

OTTAWA, Ontario, Dec. 13, 2017 /Weed Wire/ — Tetra Bio-Pharma Inc. (“Tetra” or the “Company”) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that the company has signed an exclusive research and development (R&D) agreement with Constance Therapeutics.

Alcohol sales fell by 15 percent following the introduction of medical marijuana laws in a number of states, according to a new working paper by researchers at the University of Connecticut and Georgia State University.

SEATTLE, Nov. 27, 2017 /Weed Wire/ — About 1 in 7 adult primary care patients visiting medical offices reported having used marijuana at least once in the past year, according to a study conducted by Kaiser Permanente researchers since Washington state legalized nonmedical cannabis use in 2014.

When Asi Naim, a severely autistic Israeli boy, started smacking his head against the wall and hurting himself in other ways, his parents tried every kind of psychiatric drug to calm him. Nothing worked. Then Asi entered a cannabis-based research program at Jerusalem’s Shaarei Zedek hospital.

NANAIMO, British Columbia, Nov. 8, 2017 /Weed Wire/ — Tilray, a GMP-certified global leader in medical cannabis research and production, today announced that the company has successfully exported live medical cannabis genetics from its flagship British Columbia, Canada facility to its European Union Campus in Cantanhede, Portugal.

While the United States Drug Enforcement Agency’s marijuana research license isn’t awarded lightly, an Ohio-based organization was recently awarded a Schedule I Researcher license by the DEA to study the effects of marijuana.

Rep. Matt Gaetz has been in Congress for less than a year, but the Florida Congressman has already become one of the House’s foremost leaders working to reform federal marijuana policies. Just one problem: GOP leadership doesn’t seem especially interested in giving the issue a fair shake.

In a Senate Judiciary Committee hearing Wednesday morning, Senator Orrin Hatch made the case for medical marijuana. During the hearing Hatch questioned U.S. Attorney General Jeff Sessions about a path forward for marijuana research.

Legal pot sales rose a stunning 34% in 2016 to $6.7 billion across North America, according to Arcview Market Research. But with growth this rapid, there’s bound to be more than a few marijuana stock investments that will be left behind.

While Canada is planning to delay the roll out of recreational cannabis edibles for regulatory reasons, it may give stakeholders the added benefit of having extra time to master their formulations for what may become a booming market segment.

NEW YORK, Sept. 27, 2017 /Weed Wire/ — The Green Market Report (GMR) has partnered with Consumer Research Around Cannabis to release a series of research market snapshots called ‘Cannabis Freakonomics’ highlighting interesting findings on the spending habits and profiles of cannabis consumers.

As the Golden State readies for the rollout of recreational cannabis on Jan. 1, 2018, some are preparing for a windfall of revenue from California cannabis taxes and others are preparing to continue competing with the black market.

On Sept. 13, 2017, U.S. Sen. Orrin Hatch, R-Utah, introduced legislation to cut the bureaucratic red tape thwarting medical cannabis research so health care professionals can harness the medicinal properties of the plant to reduce the suffering of patients in need.

MJINews was started to aggregate, report and opine on various ways to make money in the legal marijuana industry. While medical marijuana has been legal in many states for years, its legalization for recreational use in Colorado and Washington in 2014 has catapulted the entire subject to new heights.
Read more about us..